Clinical Trials

Showing trials with last updates posted in 2024.

NCT04659044 | TERMINATED | PHASE2
3 participants

Polatuzumab Vedotin, Venetoclax, and Rituximab and Hyaluronidase Human for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2024-09-19
Start Date:
2021-04-01
Completion:
2024-03-28
Conditions
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3a Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Refractory Grade 1 Follicular Lymphoma
  • Refractory Grade 2 Follicular Lymphoma
  • Refractory Grade 3a Follicular Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Refractory Marginal Zone Lymphoma
  • Refractory Small Lymphocytic Lymphoma
Interventions
  • DRUG
  • BIOLOGICAL
NCT04609943 | TERMINATED | PHASE1
16 participants
Previous
Sorted by latest updates
Next
Showing 40 trials per page